of different experimental arthritis models

Slides:

Advertisements

Similar presentations

Figure 1 Simplified scheme of TGFβ signalling

Advertisements

Blockade of Glucocorticoid-Induced Tumor Necrosis Factor–Receptor-Related Protein Signaling Ameliorates Murine Collagen-Induced Arthritis by Modulating Follicular.

Nat. Rev. Rheumatol. doi: /nrrheum

Figure 1 Lymphocytes during the disease

Figure 1 Role of innate lymphoid cells (ILCs) in steady state,

Nat. Rev. Nephrol. doi: /nrneph

Figure 3 The adaptive and maladaptive energy matrices

Nat. Rev. Rheumatol. doi: /nrrheum

Figure 1 Historical evolution of the clinical classification and

Figure 1 Rheumatoid arthritis development over time in relation to the level of inflammation Figure 1 | Rheumatoid arthritis development over time in relation.

Nat. Rev. Rheumatol. doi: /nrrheum

Nat. Rev. Rheumatol. doi: /nrrheum

Nat. Rev. Rheumatol. doi: /nrrheum

Figure 1 Factors underlying metabolic alterations in osteoarthritis

Figure 1 Induction of immune tolerance

Figure 4 Simplified T cell and antigen presenting

Figure 3 Proposed mechanisms underlying the links

Figure 2 Heat map of targeted therapies in autoimmune diseases

Figure 2 Main functions of IL-1

Figure 4 Involvement of SEMA4D in the pathogenesis

Nat. Rev. Rheumatol. doi: /nrrheum

Figure 3 Transcriptome studies performed in the target

Figure 2 Shared genetic loci in systemic autoimmune diseases

Figure 7 Defects in apoptosis

Nat. Rev. Rheumatol. doi: /nrrheum

Figure 3 TNFSF activities enhancing immune cell activation

Figure 1 Regulation of energy storage and energy release

Figure 2 Co-stimulatory receptors as immunomodulatory targets

Figure 4 Proinflammatory immune cells and their crosstalk in patients with IBD Figure 4 | Proinflammatory immune cells and their crosstalk in patients.

Nat. Rev. Rheumatol. doi: /nrrheum

Nat. Rev. Rheumatol. doi: /nrrheum

Figure 3 Strategies to achieve therapeutic inhibition of IL-1

Figure 4 Approaches to targeting inhibitory immune receptors

Figure 1 Activation and signalling of IL-1

Nat. Rev. Nephrol. doi: /nrneph

Nat. Rev. Rheumatol. doi: /nrrheum

Figure 2 Type 3 immunity and AS

Nat. Rev. Rheumatol. doi: /nrrheum

Figure 2 Microbiota and osteoimmunology

Figure 6 Lack of IRF5 causes a reduction in neutrophil influx

Figure 5 The role of Ly6Chi and Ly6Clo monocytes

Nat. Rev. Rheumatol. doi: /nrrheum

Figure 3 Effect of sialylated glycoforms on IgG activity

Figure 3 Multi-hit model for autoimmune diseases

Nat. Rev. Rheumatol. doi: /nrrheum

Nat. Rev. Rheumatol. doi: /nrrheum

Nat. Rev. Rheumatol. doi: /nrrheum

Figure 1 Research advances in osteoarthritis management

Figure 2 Emerging hallmarks of T cells in rheumatoid arthritis

Figure 1 Overview of biosimilar product development

Nat. Rev. Rheumatol. doi: /nrrheum

Nat. Rev. Rheumatol. doi: /nrrheum

Figure 3 Inflammatory mechanisms in tendinopathy

Figure 1 Treat to target, remission and low disease activity in SLE

Figure 1 The current model of the pathogenesis of SLE

Nat. Rev. Rheumatol. doi: /nrrheum

Nat. Rev. Rheumatol. doi: /nrrheum

Figure 2 GM-CSF — a key player in inflammation and autoimmunity

Figure 1 Transmission of pain by NGF

Nat. Rev. Rheumatol. doi: /nrrheum

Figure 2 Biologics that target CD4+ T helper (TH)-cell subsets

Nat. Rev. Rheumatol. doi: /nrrheum

Figure 4 The relationship between the time-dependent changes in the expression of immunoglobulin, mast cell, acute kidney injury (AKI), and fibrillar collagen.

Nat. Rev. Rheumatol. doi: /nrrheum

Nat. Rev. Rheumatol. doi: /nrrheum

Figure 1 Patterns of joint and organ involvement in rheumatic disease

Figure 4 Role of chemokines in dendritic cell migration

Figure 1 Extrinsic and intrinsic pathways of apoptosis

Figure 1 The role of macrophages in RA

Nat. Rev. Rheumatol. doi: /nrrheum

Presentation transcript:

of different experimental arthritis models Figure 2 Overview of the role of IL‑17/IL‑17RA and IL‑23 signalling during the pathogenesis of different experimental arthritis models Figure 2 | Overview of the role of IL-17/IL-17RA and IL-23 signalling during the pathogenesis of different experimental arthritis models. a | The effects of IL-23p19 knock-out, IL-17A knock-out and IL-17RA knock-out on the development of autoimmune CIA. Therapeutic intervention with neutralization of IL-23p19 or IL-17A during different stages of CIA either has no effect or has beneficial effects on the progression of the disease, as assessed by clinical scores. b | The effect of IL-23p19 knock-out and IL-17RA knock-out on the development of a T-cell-driven monoarthritis using the mBSA AIA model. The effect of neutralizing IL-17A or IL-23p19 on the progression of arthritis as well as during a flare-up of the arthritis was monitored by clinical scores. Abbreviations: AIA, antigen-induced arthritis; CII, type II collagen; CIA, collagen-induced arthritis; FcγR, Fcγ receptor; IC, immune complex, IL-17RA, IL-17 receptor subunit A; mBSA, methylated bovine serum albumin; TH cell, T helper cell. Lubberts, E. (2015) The IL‑23–IL‑17 axis in inflammatory arthritis Nat. Rev. Rheumatol. doi:10.1038/nrrheum.2015.53